Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Galindo, G
Accessed 10/26/2015
Documented areas of research interest include: Melanocortin receptor (MC1R to MC5R) agonism and signalling Melanogenesis and melanocyte biology in cell models (MC1R) MC4R-mediated appetite and energy-balance pathways in animal models All research applications are non-clinical
& Luthman, H
Prolia (denosumab) Disease area(s): Bone health Manufacturer(s): Amgen 2024 Sales (USD): $4.37 billion Why it sold so well: In 2024, Amgens Prolia achieved strong sales, with global revenues increasing by 8% year-over-year to $4.37 billion for the year, driven primarily by volume growth
US$ 29.23
US$ 27.39
US$ 24.80
-Western-Blot-NB100-344-img0004.jpg-650.jpg)
US$ 24.78
-Immunohistochemistry-NB100-344-img0003.jpg-650.jpg)
US$ 20.91
